Chromatographic determination of clotrimazole, ketoconazole and fluconazole in pharmaceutical formulations

被引:85
作者
Abdel-Moety, EM [1 ]
Khattab, FI [1 ]
Kelani, KM [1 ]
AbouAl-Alamein, AM [1 ]
机构
[1] Cairo Univ, Fac Pharm, ET-11562 Cairo, Egypt
来源
FARMACO | 2002年 / 57卷 / 11期
关键词
clotrimazole; fluconazole; imidazole; HPLC and TLC chromatography; ketoconazole;
D O I
10.1016/S0014-827X(02)01270-3
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
High-performance liquid chromatographic technique has been developed for the determination or some azolcsantifungals namely, clotrimazole (CZ), ketoconazole (KZ) and fluconazole (FZ), in pure forms and in pharmaceutical formulations. The proposed HPLC-method can be successfully applied as a stability indicating method for the determination of CZ in presence of its acid degradation products; viz (2-chlorophenyl) -diphenyl methanol and imidazole. The analyzed drugs were separated on a reversed phase column [Bondapak(TM) C-18 (10 mum, 25 cm x 4.6 mm, i.d.)] using a mobile phase containing acetonitrilc+25 mM trishydroxymeihyl aminomethane in phosphate butter (pH 7) = 55:45 (v/v), with UV-detection at 260 nm. The differences in the retention times (t(R)) of the three azoles permit their use as internal standard for each other. In addition, a coupled TLC-densitometric method has been also applied as a stability indicating method to separate and quantify CZ alone or in presence of byproducts impurities and/or its acid degradation products. The TLC-fractionation was performed on a precoated silica gel F-254 plates using a solvent system consisting of chloroform +acetone+ammonia (25%) (7:1:0.1, by volumes), CZ was well separated from its acid degradation products and quantified by densitometric scanning at 260 nm. (C) 2002 Editions scientifiques et medicales Elsevier SAS. All rights reserved.
引用
收藏
页码:931 / 938
页数:8
相关论文
共 36 条
[1]  
ASHWORTH RA, 1991, ASHP MID CLIN M, V26, pE572
[2]   THE DEVELOPMENT AND APPLICATION OF COUPLED HPLC-TLC FOR PHARMACEUTICAL ANALYSIS [J].
BANKS, CT .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1993, 11 (08) :705-710
[3]  
BEDAIR MM, 1989, J ASSOC OFF ANA CHEM, V72, P423
[4]   GAS-CHROMATOGRAPHIC ANALYSIS, WITH ELECTRON-CAPTURE DETECTION, OF THE ANTIFUNGAL DRUG FLUCONAZOLE IN MICROVOLUMES OF HUMAN PLASMA [J].
BEIJNEN, JH ;
MEENHORST, PL ;
VANGIJN, R ;
HAZELAGER, WA ;
KOKS, CHW ;
UNDERBERG, WJM .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1991, 9 (10-12) :1173-1175
[5]  
BUDAVARIS S, 1996, MERCK INDEX, V2478, P410
[6]   High-performance liquid chromatographic determination of fluconazole in plasma [J].
Cociglio, M ;
Brandissou, S ;
Alric, R ;
Bressolle, F .
JOURNAL OF CHROMATOGRAPHY B-BIOMEDICAL APPLICATIONS, 1996, 686 (01) :11-17
[7]   Spectral characterization of fluconazole [J].
Cyr, TD ;
Dawson, BA ;
Neville, GA ;
Shurvell, HF .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1996, 14 (03) :247-255
[8]  
DANIEL WW, 1991, BIOSTATISTICS FDN AN
[9]  
Dean JR, 1997, J AOAC INT, V80, P7
[10]  
El-Shabouri SR, 1998, ANAL LETT, V31, P1367, DOI 10.1080/00032719808002873